• CERAHEAD

    Symptomatic treatment of vertigo. Elderly suffering from loss of memory, vertigo, lack of concentration or alertness, changes of mood, deterioration in behaviour, personal negligence, dementia…
  • CERAHEAD-F

    Symptomatic treatment of vertigo. Elderly suffering from loss of memory, vertigo, lack of concentration or alertness, changes of mood, deterioration in behaviour, personal negligence, dementia…
  • DAVYCA

    [pdf-embedder url="https://davipharm.info/wp-content/uploads/DAVYCA_07.pdf"]
  • DAVYCA-F

    [pdf-embedder url="https://davipharm.info/wp-content/uploads/DAVYCA_F.pdf"]
  • DERUFF-4

    Symptomatic treatment off mild to moderately severe Alzheimer's dementia. This is only the preview. Please check here for the full indication.
  • DIVASER – F

    [pdf-embedder url="https://davipharm.info/wp-content/uploads/DIVASER-F_toa.pdf"]
  • EVALDEZ

    Relief of symptoms of dyspeptic syndrome: bloating, epigastric discomfort, heartburn, belching, nausea, vomiting. Treatment of acute and chronic schizophrenia. This is only the preview. Please…
  • GAYAX

    Amisulprid is indicated for the treatment of acute and chronic schizophrenic disorders in which positive symptoms (such as delusions, hallucinations and thought disorders) and/or negative…
  • GAYAX-400

    Amisulprid is indicated for the treatment of acute and chronic schizophrenic disorders in which positive symptoms (such as delusions, hallucinations and thought disorders) and/or negative…
  • GINKNEX

    Support for the treatment of dementia, poor concentration. Support for the treatment of pain symptoms due to circulatory failure in peripheral arteries such as angina…
  • KAUSKAS-100

    Epilepsy Adults and adolescents aged 13 years and above - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - Seizures…
  • KAUSKAS-200

    Epilepsy Adults and adolescents aged 13 years and above - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - Seizures…
  • KAUSKAS-50

    Epilepsy Adults and adolescents aged 13 years and above - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - Seizures…
  • KEIKAI

    Monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over. This is only…
  • LEVETRAL

    Monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed…
  • LEVETRAL-750

    Monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed…
  • MANZURA-15

    Treatment of schizophrenia. Maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Treatment of moderate to severe manic…
  • MANZURA-5

    Treatment of schizophrenia. Maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Treatment of moderate to severe manic…